Whole-body Hyperthermia for Depression - Trial NCT06323785
Access comprehensive clinical trial information for NCT06323785 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Zurich and is currently Recruiting. The study focuses on Major Depressive Disorder. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Zurich
Timeline & Enrollment
N/A
Apr 30, 2024
Mar 01, 2026
Primary Outcome
Hamilton Rating Scale for Depression (HAMD-17; minimum: 0, maximum: 68, higher scores indicate higher depression)
Summary
The goal of this clinical trial is to test the efficacy of whole-body hyperthermia in major
 depression. The main question it aims to answer is:
 
 • Does whole-body hyperthermia alleviate symptoms of depression?
 
 Participants will be randomised to sham or active whole-body hyperthermia. The study will
 last 6 weeks during which five visits will take place. Depression will be measured repeatedly
 and biological mechanisms will be investigated.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06323785
Device Trial